Trial Profile
An Open Label, Single Dose Metabolism and Mass Balance Study of 14C-ABR-215050 in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Oct 2014
Price :
$35
*
At a glance
- Drugs Tasquinimod (Primary)
- Indications Gynaecological cancer; Prostate cancer
- Focus Pharmacokinetics
- 22 Jan 2010 New trial record